LOTRIDERM DIN 00611174
Status: Marketed
Holder: ORGANON CANADA INC.
Available to quote
Health Canada record
| Active ingredient(s) | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 %; CLOTRIMAZOLE 1 % |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D01AC20 IMIDAZOLES/TRIAZOLES IN COMBINATION WITH CORTICOSTEROIDS |
| Original market date | 31-Dec-1990 |
| Current status date | 10-Mar-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Organon Canada Inc. — licence 3-002674, currently licensed, last inspection rating C (2025-11-06).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BETAMETHASONE (BETAMETHASONE DIPROPIONATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00629367 | DIPROLENE | ORGANON CANADA INC. | Ointment | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Marketed |
| 00578436 | DIPROSALIC | ORGANON CANADA INC. | Ointment | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG; SALICYLIC ACID 30 MG | Marketed |
| 00417246 | DIPROSONE | ORGANON CANADA INC. | Lotion | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Marketed |
| 00323071 | DIPROSONE | ORGANON CANADA INC. | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Marketed |
| 00344923 | DIPROSONE | ORGANON CANADA INC. | Ointment | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Marketed |
| 02457393 | ENSTILAR | LEO PHARMA INC | Aerosol (Foam) | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG; CALCIPOTRIOL (CALCIPOTRIOL MONOHYDRATE) 50 MCG | Marketed |
| 02496410 | TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE | TARO PHARMACEUTICALS INC | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 %; CLOTRIMAZOLE 1 % | Marketed |
| 01925350 | TARO-SONE | TARO PHARMACEUTICALS INC | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Marketed |
| 02427419 | TEVA-BETAMETHASONE/ CALCIPOTRIOL | TEVA CANADA LIMITED | Ointment | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG; CALCIPOTRIOL 50 MCG | Marketed |
| 00849650 | TEVA-TOPILENE | TEVA CANADA LIMITED | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Marketed |
| 00849669 | TEVA-TOPILENE | TEVA CANADA LIMITED | Ointment | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Marketed |
| 01927914 | TEVA-TOPILENE | TEVA CANADA LIMITED | Lotion | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Marketed |
| 00809187 | TEVA-TOPISONE | TEVA CANADA LIMITED | Lotion | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Marketed |
| 00804991 | TEVA-TOPISONE | TEVA CANADA LIMITED | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Marketed |
| 00805009 | TEVA-TOPISONE | TEVA CANADA LIMITED | Ointment | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Marketed |
| 02563010 | WYNZORA | KNIGHT THERAPEUTICS INC. | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG; CALCIPOTRIOL 0.05 MG | Marketed |
| 00417262 | DIPROGEN CREAM | MERCK CANADA INC | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 %; GENTAMICIN (GENTAMICIN SULFATE) 0.1 % | Cancelled Post Market |
| 00417254 | DIPROGEN OINTMENT | MERCK CANADA INC | Ointment | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 %; GENTAMICIN (GENTAMICIN SULFATE) 0.1 % | Cancelled Post Market |
| 00862975 | DIPROLENE | MERCK CANADA INC | Lotion | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Cancelled Post Market |
| 00688622 | DIPROLENE | MERCK CANADA INC | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Cancelled Post Market |
| 00578428 | DIPROSALIC | ORGANON CANADA INC. | Lotion | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG; SALICYLIC ACID 20 MG | Cancelled Post Market |
| 02244766 | PMS-CLOTRIMAZOLE-BETAMETHASONE | PHARMASCIENCE INC | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 %; CLOTRIMAZOLE 1 % | Cancelled Pre Market |
| 02217872 | PRO-LENE GLYCOL CREAM - 0.05% | PRO DOC LIMITEE | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Cancelled Post Market |
| 02217864 | PRO-LENE GLYCOL LOTION - 0.05% | PRO DOC LIMITEE | Lotion | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Cancelled Post Market |
| 02217880 | PRO-LENE GLYCOL OINTMENT - 0.05% | PRO DOC LIMITEE | Ointment | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Cancelled Post Market |
| 02217848 | PRO-SONE CREAM - 0.05% | PRO DOC LIMITEE | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Cancelled Post Market |
| 02245688 | RATIO-TOPISALIC | TEVA CANADA LIMITED | Lotion | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG; SALICYLIC ACID 20 MG | Cancelled Post Market |
| 02122073 | ROLENE CREAM | LABORATOIRE RIVA INC. | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Dormant |
| 02122065 | ROLENE LOTION | LABORATOIRE RIVA INC. | Lotion | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Dormant |
| 02122081 | ROLENE OINTMENT | LABORATOIRE RIVA INC. | Ointment | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Dormant |
| 02122049 | ROSONE CREAM | LABORATOIRE RIVA INC. | Cream | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Dormant |
| 02122030 | ROSONE LOTION | LABORATOIRE RIVA INC. | Lotion | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Dormant |
| 02122057 | ROSONE OINTMENT | LABORATOIRE RIVA INC. | Ointment | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Dormant |
| 01944444 | TARO SONE LOT 0.05% | TARO PHARMACEUTICALS INC | Lotion | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Cancelled Post Market |
| 01944436 | TARO SONE ONT | TARO PHARMACEUTICALS INC | Ointment | BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 25710 | 2021-04-21 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 12172 | 2011-03-17 | New Drug Submission (NDS) | Manufacturer name change |